البحث عن طبيب

Christine L. Klassen, M.D.

  1. Internist

المنشورات

  1. Cornell LF, Klassen CL, Ghosh K, Ball C, Advani P, Pruthi S. Improved Uptake and Adherence to Risk-Reducing Medication with the Use of Low-Dose Tamoxifen in Patients at High Risk for Breast Cancer. Cancer Prev Res (Phila). 2024 Dec 3; 17 (12):565-570
    View PubMed
  2. Black DM, Day CN, Piltin MA, Klassen CL, Pruthi S, Hieken TJ. Racial/ethnic differences in tumor biology and treatment outcomes in women with ductal carcinoma in situ. Surgery. 2024 Nov 26; 108940 [Epub ahead of print]
    View PubMed
  3. Sahni SK, Fraker JL, Cornell LF, Klassen CL. Hormone therapy in women with benign breast disease - What little is known and suggestions for clinical implementation. Maturitas. 2024 Jul; 185:107992 Epub 2024 Apr 06
    View PubMed
  4. Klassen CL, Viers LD, Ghosh K. Following the High-Risk Patient: Breast Cancer Risk-Based Screening. Ann Surg Oncol. 2024 May; 31 (5):3154-3159 Epub 2024 Feb 01
    View PubMed
  5. Steadman JA, Hoskin TL, Klassen C, Boughey JC, Degnim AC, Piltin MA, Mrdutt MM, Johnson JE, Hieken TJ. Assessment of the effect of the American Society of Breast Surgery guidelines on contralateral prophylactic mastectomy rates for unilateral breast cancer. Surgery. 2024 Mar; 175 (3):677-686 Epub 2023 Oct 19
    View PubMed
  6. Vegunta S, Mussallem DM, Kaur AS, Pruthi S, Klassen CL. Atypical hyperplasia of the breast: Clinical cases and management strategies. Cleve Clin J Med. 2023 Jul 3; 90 (7):423-431 Epub 2023 July 03
    View PubMed
  7. Klassen CL, Gilman E, Kaur A, Lester SP, Pruthi S. Breast cancer risk evaluation for the primary care physician. Cleve Clin J Med. 2022 Mar 1; 89 (3):139-146 Epub 2022 Mar 01
    View PubMed
  8. Klassen C, Gilman E, Lester SP, Kaur A, Pruthi S. A Systematic Approach to Breast Cancer Risk Evaluation for the Primary Care Physician Cleveland Clinic Journal of Medicine. 9/10/2021.
  9. Pruthi S, Mussallem DM, Cornell LF, Klassen CL, Kling JM. Reducing Breast Cancer Incidence and Mortality: Rethinking an Approach to Risk Assessment and Prevention. JCO Oncol Pract 2021 Dec; 17 (12):717-719 Epub 2021 Sept 07
    View PubMed
  10. Yadav S, Hu C, Hart SN, Boddicker N, Polley EC, Na J, Gnanaolivu R, Lee KY, Lindstrom T, Armasu S, Fitz-Gibbon P, Ghosh K, Stan DL, Pruthi S, Neal L, Sandhu N, Rhodes DJ, Klassen C, Peethambaram PP, Haddad TC, Olson JE, Hoskin TL, Goetz MP, Domchek SM, Boughey JC, Ruddy KJ, Couch FJ. Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer. J Clin Oncol. 2020 May 1; 38 (13):1409-1418 Epub 2020 Mar 03
    View PubMed
  11. Dilaveri C, Klassen C, Fazzio R, Ghosh K. Breast cancer screening for women at average risk Current Breast Cancer Reports. 2019 Sep; 11(3):123-8. Epub 1900 Jan 01.
  12. Klassen CL, Hines SL, Ghosh K. Common benign breast concerns for the primary care physician. Cleve Clin J Med. 2019 Jan; 86 (1):57-65
    View PubMed
  13. Sakata KK, Azadeh N, Brighton A, Temkit M, Klassen CL, Grys TE, Vikram HR. Impact of Nasopharyngeal FilmArray Respiratory Panel Results on Antimicrobial Decisions in Hospitalized Patients. Can Respir J. 2018; 2018:9821426 Epub 2018 June 13
    View PubMed
  14. Sakata KK, Klassen CL, Bollin KB, Grys TE, Slack JL, Wesselius LJ, Vikram HR. Microbiologic yield of bronchoalveolar lavage specimens from stem cell transplant recipients. Transpl Infect Dis. 2017 Jun; 19 (3) Epub 2017 Apr 12
    View PubMed
  15. Padrnos LJ, Barr PJ, Klassen CL, Fields HE, Azadeh N, Mendoza N, Saadiq RA, Pauwels EM, King CS, Chung AA, Sakata KK, Blair JE. Introducing routine HIV screening for patients on an internal medicine residency inpatient service: a quality improvement project. BMJ Qual Improv Rep. 2016; 5 (1) Epub 2016 May 05
    View PubMed
  16. Barrett MT, Anderson KS, Lenkiewicz E, Andreozzi M, Cunliffe HE, Klassen CL, Dueck AC, McCullough AE, Reddy SK, Ramanathan RK, Northfelt DW, Pockaj BA. Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer. Oncotarget. 2015 Sep 22; 6 (28):26483-93
    View PubMed
  17. Cohen-Barak O, Erickson DT, Badowski MS, Fuchs DA, Klassen CL, Harris DT, Brilliant MH. Stem cell transplantation demonstrates that Sox6 represses epsilon y globin expression in definitive erythropoiesis of adult mice. Exp Hematol. 2007 Mar; 35(3):358-67.
    View PubMed